Medical Radiology and Radiation Safety. 2026. Vol. 71. № 6

DOI:10.33266/1024-6177-2026-71-6-122-126

M.S. Kani, Yu.S. Pyshkina

MRI IN PLANNING AND FOLLOW‑UP OF PITUITARY ADENOMAS AFTER GAMMA KNIFE RADIOSURGERY

A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

Contact person: Yu.S. Pyshkina, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.  

ABSTRACT

Purpose: To evaluate the efficacy of Gamma Knife stereotactic radiosurgery under magnetic resonance imaging guidance in patients with pituitary adenomas.

Material and methods: A retrospective, single-center case series study was conducted. The analysis included 19 patients with pituitary adenomas treated between November 2023 and December 2025, comprising 15 women (78.9%) and 4 men (21.1 %), with a median age of 58.7 years (range, 41–75 years). A prior surgical procedure (endoscopic endonasal transsphenoidal surgery) had been performed in 78.9 % (n=15) of patients. All patients underwent stereotactic radiosurgery (SRS) on a Leksell Gamma Knife unit. Magnetic resonance imaging (MRI) of the brain was performed in all subjects using T1-weighted images (WI); T2-WI; contrast‑enhanced T1-WI; and contrast‑enhanced T1‑WI with fat-signal suppression. Pituitary adenoma volumes were assessed using the Leksell GammaPlan software by manual contouring of the target on contrast‑enhanced T1-WI.

Results: Following stereotactic radiosurgery, pituitary adenoma volumes ranged from 0.431 to 19.785 cm³ (mean, 6.73 cm³). The mean difference between target volumes before SRS and on follow-up MRI of the brain was 1.99 cm³, which was statistically significant (p < 0.05). In one patient (5.3 %), the lesion reduced in volume by half. In the remaining 18 patients (94.7 %), tumor growth was controlled without further progression. During the follow-up period, no worsening of neurological symptoms or new neurological deficits was observed in any patient.

Conclusion: Stereotactic radiosurgery on the Gamma Knife under MRI guidance represents a safe and effective treatment modality for pituitary adenomas, providing tumor growth control in the vast majority of patients and statistically significant volumetric reduction. The use of standardized MRI protocols at the planning and dynamic follow‑up stages is essential for achieving optimal clinical outcomes.

 

Keywords: stereotactic radiosurgery, gamma knife, pituitary adenoma, magnetic resonance imaging

For citation: Kani MS, Pyshkina YuS. MRI in Planning and Follow‑up of Pituitary Adenomas after Gamma Knife Radiosurgery. Medical Radiology and Radiation Safety. 2026;71(6):122–126. DOI:10.33266/1024-6177-2026-71-6-122-126

 

References

1. Garg K., Singh M. Role of Stereotactic Radiosurgery in Pituitary Adenomas. Neurol India. 2020;68;Suppl: S123-S128. Doi: 10.4103/0028-3886.287674. PMID: 32611902.

2. Курносов А.Б., Кутин М.А., Шарипов О.И., Калинин П.Л., Фомичев Д.В., Малеваная Н.В. Эффективность применения гипертонического солевого раствора для достижения устойчивой интраоперационной внутричерепной гипотензии в эндоскопической эндоназальной транссфеноидальной хирургии // Неотложная медицинская помощь. Журнал им. Н.В. Склифосовского. 2020. Т.9. №3. С. 363-368 [Kurnosov A.B., Kutin M.A., Sharipov O.I., Kalinin P.L., Fomichev D.V., Malevanaya N.V. Efficiency of Using Hypertonic Saline Solution to Achieve Stable Intraoperative Intracranial Hypotension in Endoscopic Endonasal Transsphenoidal Surgery. Neotlozhnaya Meditsinskaya Pomoshch’. Zhurnal im. N.V. Sklifosovskogo = Russian Sklifosovsky Journal of Emergency Medical Care. 2020;9;3:363-368 (In Russ.)]. Doi: 10.23934/2223-9022-2020-9-3-363-368.

3. Kim I., Yan M., Sourour M., Heaton R., Faulkner C., Kalyvas A., Keilty D.M., Cusimano M.D., Payne D., Laperriere N., Shultz D.B., Alli S.B., Zadeh G., Tsang D.S. Pituitary Neuroendocrine Tumors Treated with Stereotactic Radiosurgery. J Neurooncol. 2025;171;2:423-430. Doi: 10.1007/s11060-024-04864-3. PMID: 39466561.

4. Zheng B., Zhao Z., Zheng P., Liu Q., Li S., Jiang X., Huang X., Ye Y., Wang H. The Current State of MRI-Based Radiomics in Pituitary Adenoma: Promising but Challenging. Front Endocrinol (Lausanne). 2024;15:1426781. Doi: 10.3389/fendo.2024.1426781. PMID: 39371931.

5. Manuweera T., Karunakaran K., Baechler C., Rosales J., Kleckner A.S., Rosenblatt P., Ciner A., Kleckner I.R. Barriers and Facilitators for Participation in Brain Magnetic Resonance Imaging (MRI) Scans in Cancer Research: a Feasibility and Acceptability Analysis. Res Sq [Preprint]. 2024:rs.3.rs-4595719. Doi: 10.21203/rs.3.rs-4595719/v1. Update in: Support Care Cancer. 2025;33;6:497. Doi: 10.1007/s00520-025-09549-9. PMID: 39070661.

6. Bashari W.A., Senanayake R., Fernández-Pombo A., Gillett D., Koulouri O., Powlson A.S., Matys T., Scoffings D., Cheow H., Mendichovszky I., Gurnell M. Modern Imaging of Pituitary Adenomas. Best Pract Res Clin Endocrinol Metab. 2019;33;2:101278. Doi: 10.1016/j.beem.2019.05.002. PMID: 31208872.

7. Первичные опухоли центральной нервной системы: Клинические рекомендации. М.: Минздрав России, 2025. 99 с.  [Pervichnyye Opukholi Tsentral’noy Nervnoy Sistemy = Primary Tumors of the Central Nervous System: Clinical Guidelines. Moscow, Ministry of Health of the Russian Federation Publ., 2025. 99 p. (In Russ.)]. URL: https://clck.ru/3FQKZU.

8. Gadelha M.R., Barbosa M.A., Lamback E.B., Wildemberg L.E., Kasuki L., Ventura N. Pituitary MRI Standard and Advanced Sequences: Role in the Diagnosis and Characterization of Pituitary Adenomas. J Clin Endocrinol Metab. 2022;107;5:1431-1440. Doi: 10.1210/clinem/dgab901. PMID: 34908114.

9. O’Connor J.P., Rose C.J., Waterton J.C., Carano R.A., Parker G.J., Jackson A. Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome. Clin Cancer Res. 2015;21;2:249-57. Doi: 10.1158/1078-0432.CCR-14-0990. PMID: 25421725.

10. Sav A. Editorial: Diagnosis and Treatment of Non-Functioning Pituitary Tumors. Front Endocrinol (Lausanne). 2025;16:1558988. Doi: 10.3389/fendo.2025.1558988. PMID: 40248145.

11. Захарова Н.Е., Пронин И.Н., Баталов А.И., Чехонин И.В., Тюрина А.Н. Визуализация опухолей головного мозга: снова о стандартизированном МРТ-протоколе // Радиология – практика. 2024. №1. С. 66-84 [Zakharova N.Ye., Pronin I.N., Batalov A.I., Chekhonin I.V., Tyurina A.N. Visualization of Brain Tumors: again about the Standardized MRI Protocol. Radiologiya – Praktika = Radiology – Practice. 2024;1:66-84 (In Russ.)]. Doi: 10.52560/2713-0118-2024-1-66-84.

12. Wei N., Gunawan K., Tsai C.L., Yang S.H., Hsu F.M., Lai D.M., Xiao F. Long-Term Outcomes after CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas. Neurosurgery. 2025;96;4:892-900. Doi: 10.1227/neu.0000000000003174. PMID: 39264192.

13. Arkawazi B.M.F., Al Atraqchi A., Adnan A., Dheyab S. Efficacy of Gamma Knife Radiosurgery in the Management of Pituitary Prolactinoma. Surg Neurol Int. 2021;12:357. Doi: 10.25259/SNI_230_2021. PMID: 34345497.

14. Mathieu D., Kotecha R., Sahgal A., De Salles A., Fariselli L., Pollock B.E., Levivier M., Ma L., Paddick I., Regis J., Yomo S., Suh J.H., Rubens M., Sheehan J.P. Stereotactic Radiosurgery for Secretory Pituitary Adenomas: Systematic Review and International Stereotactic Radiosurgery Society Practice Recommendations. J Neurosurg. 2021;136;3:801-812. Doi: 10.3171/2021.2.JNS204440. PMID: 34479203.

15. Slavinsky P., Gonzalez Pernas M., Miragaya K., Antico J., Margni A., Condomí Alcorta M., Katz D.A. Gamma Knife Radiosurgery in Pituitary Adenomas. A Single-Center Experience. Medicina (B Aires). 2022;82;1:111-116. PMID: 35037869.

16. Sud S., Botticello T., Niemierko A., Daly J., Bussiere M., Shih H.A. Dosimetric Comparison of Proton Versus Photon Radiosurgery for Treatment of Pituitary Adenoma. Adv Radiat Oncol. 2021;6;6:100806. Doi: 10.1016/j.adro.2021.100806. PMID: 34934865.

17. La Rosa A., Wroe A., Fellows Z., Kotecha R. Proton Radiosurgery: Current Concepts and Limitations for CNS Radiosurgery. Neurol India. 2023;71;12 Suppl 2:S174-S182. Doi: 10.4103/0028-3886.373636. PMID: 37026350.

18. Zarei F., Nematollahi F., Jalil A., Zeinali-Rafsanjani B., Saeedi-Moghadam M. Rethinking MRI Protocols for Pituitary Microadenomas: Prioritizing Non-Contrast Imaging for Safe Follow-Up. Tomography. 2025;11;9:105. Doi: 10.3390/tomography11090105. PMID: 41003488.

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest.The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Pyshkina Yu.S.: development of the research concept, development of the research design; development and modification of research methods, writing and scientific editing of the text; Kani M.S.: conduct of research, collection and analysis of literary material, statistical data processing, writing of the text.

Article received: 20.06.2026. Accepted for publication: 25.07.2026